ArticleJournal of personalized medicine2025

Comparison of Hepatic Function and Chemotherapy-Induced Side Effects Between Pegylated Liposomal Doxorubicin (PLD), Topotecan (TOPO), and Gemcitabine in Platinum-Resistant Ovarian Cancer (PROC).

Radu-Dumitru Dragomir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.